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GABAergic Stimulation Regulates the Phenotype
of Hippocampal Interneurons through the Regulation
of Brain-Derived Neurotrophic Factor
Serge Marty, Benedikt Berninger, Patrick Carroll, likely target for BDNF. Interestingly, hippocampal in-
terneurons do not express BDNF themselves (Ernforsand Hans Thoenen
Department of Neurochemistry et al., 1990; M. Berzaghi, personal communication), indi-
cating a paracrine rather than an autocrine action ofMax Planck Institute for Psychiatry
Am Klopferspitz 18A BDNF.
The levels of BDNF mRNA in the hippocampus are up-D-82152 Martinsried
Federal Republic of Germany regulated by glutamatergic stimulation, due to calcium
influx through voltage-gated calcium channels (Zafra et
al., 1991, 1992). GABAergic stimulation switches from
enhancing to repressing BDNF mRNA synthesis duringSummary
the maturation of hippocampal neurons in vitro, linked
to a loss in its ability to activate voltage-gated calciumg-Aminobutyric acid (GABA) switches from enhancing
channels (Berninger et al., 1995). Therefore, we hypothe-to repressing brain-derived neurotrophic factor
sized that via the release of GABA interneurons may(BDNF) mRNA synthesis during the maturation of hip-
control their own phenotype by regulating BDNF expres-pocampal neurons in vitro. Interneurons do not pro-
sion and release in adjacent cells.duce BDNF themselves, but BDNF enhances their dif-
ferentiation. Therefore, the question arose whether
hippocampal interneurons regulate their phenotype by Results
regulating BDNF expression and release from adja-
cent cells. The GABAA receptor agonist muscimol and Muscimol Promotes the Differentiation of
Immature Hippocampal InterneuronsBDNF increased the size and neuropeptide Y (NPY)
immunoreactivity of hippocampal interneurons. How- Treatment of hippocampal cultures with 100 mM of the
GABAA receptor agonist muscimol for 6 days (startingever, GABAergic stimulation failed to increase NPY
immunoreactivity in cultures from BDNF knockout 1 day after plating) increased the soma area of GABA-
immunoreactive neurons by 30% (Figures 1a, 1b, andembryos. At later developmental stages, when GABA
represses BDNF synthesis, treatment with muscimol 2a), but did not change the intensity of the GABA immu-
nostaining. The same treatment also resulted in a dou-induced a decrease in cell size and NPY immunoreac-
tivity of interneurons. Interneurons might thus control bling of NPY-immunoreactive neurons, which exhibited
more intense NPY immunostaining of neurites (Figurestheir phenotype through the regulation of BDNF syn-
thesis in, and release from, their target neurons. 1c, 1d, and 2b). No changes in either the total number
of cells (Figure 2c), or in the number of GABAergic cells
(Figure 2d) were observed. Furthermore, the mean somaIntroduction
area of microtubule-associated protein 2 (MAP2)-posi-
tive neurons was unchanged (Figure 2e), indicating thatg-Aminobutyric acid (GABA), the main inhibitory trans-
the effect of muscimol on soma size was specific tomitter in the adult brain, depolarizes various types of
GABAergic neurons.developing neurons via GABAA receptor activation, in-
Additional experiments established the specificity ofcluding hippocampal neurons (Ben-Ari et al., 1989). This
the stimulation with muscimol. Treatment for 6 daysdepolarization results in calcium influx through voltage-
(starting 1 day after plating) with 1 mM muscimol wasgated calcium channels (Yuste and Katz, 1991). GABA
as efficient as 100 mM muscimol to increase the somawas also found to enhance neuritic outgrowth and syn-
area and NPY expression of interneurons, and theseaptogenesis (Eins et al., 1983) and to induce the synthe-
effects were abolished by 10 mM of the GABAA receptorsis of GABAA receptor subunits (Schousboe and
antagonist bicuculline (Figures 2f and 2g). The effectsRedburn, 1995). Although it was hypothesized that these
of 10 mM muscimol were also antagonized by 10 mMtrophic effects were linked to the depolarizing action of
bicuculline (data not shown). Treatmentwith 10mM mus-GABA on young neurons, the underlying mechanism has
cimol for 1 day (starting 5 days after plating) was suffi-remained elusive.
cient to double the number of NPY-positive neuronsBrain-derived neurotrophic factor (BDNF) is a member
(data not shown). Bicuculline treatment alone neitherof the neurotrophin family widely expressed in the cen-
affected the soma size nor NPY expression of interneu-tral nervous system (Hofer et al., 1990), where its func-
rons (Figures 2f and 2g).tion is poorly understood. Expression of calbindin-D,
parvalbumin, and neuropeptide Y (NPY) was reduced in
hippocampal interneurons of BDNF-deficient mice Involvement of BDNF in the Effects of Muscimol
on Immature Hippocampal Interneurons(Jones et al., 1994). BDNF up-regulated the expression
of specific neuropeptides and calcium-binding proteins Application of 20 ng/ml BDNF for 6 days (starting 1 day
after plating) induced a 60% increase of the soma areaand promoted dendritic elongation of these neurons
(Nawa et al., 1994; Marty et al., 1996). These data, to- of the GABAergic neurons (Figure 2a) and a 3.5-fold
increase in the number of NPY-immunoreactive neuronsgether with the expression of the BDNF receptor trkB
by nonpyramidal neurons (Altar et al., 1994; Marty et (Figure 2b). BDNF neither changed the total number of
cells (Figure 2c), nor the number of GABAergic neuronsal., 1996), suggested hippocampal interneurons to be a
Neuron
566
Figure 1. Effects of Muscimol on Interneur-
ons after 1 Week In Vitro
GABAergic neurons in control (a) and musci-
mol-treated (b) cultures. NPY-immunoreac-
tive neurons in control (c) and muscimol-
treated (d) cultures. The cultures were treated
with 100 mM muscimol for 6 days (starting 1
day after plating). Scale bar, 50 mm.
(Figure 2d). The mean size of MAP2-positive neurons Treatment with 100 mM muscimol for 6 days (starting
15 days after plating) induced a marked atrophy ofwas unchanged (Figure 2e).
In cultures from BDNF (2/2) mice, the basal levels of GABA-immunoreactive neurons (Figure 3b). The size of
the cell bodies was reduced by 45% (Figure 4a), andNPY immunoreactivity varied according to the genotype
of the embryos. Cultures from BDNF (1/2) animals con- the number of primary dendrites was decreased by 30%
(Figure 4b). The number of NPY-positive neurons wastained 28% less NPY-immunoreactive neurons than cul-
tures from wild-type BDNF (1/1) embryos, while cul- decreased by 40% (Figure 4c). These alterations oc-
curred withoutchanges ineither the total numberof cellstures from homozygous BDNF knockout animals
contained 83% less NPY-immunoreactive neurons than (Figure 4d), or total number of GABA-immunoreactive
neurons (Figure 4e). The decrease in soma size ofcultures from BDNF (1/2) animals (Table 1). Moreover,
after stimulation with 100 mM muscimol, cultures from GABAergic neurons was progressive, since it was not
observed after 1 day of muscimol treatment (Figure 4f).wild-type embryos showed a stronger increase in the
number of NPY-immunoreactive neurons than cultures
from BDNF (1/2) animals, and cultures from BDNF Discussion
(2/2) animals failed to respond to muscimol by an in-
crease in NPY immunoreactivity (Table 1). During the first week in vitro, GABAA receptor activation
via muscimol increases the size of GABAergic neurons,To verify that cultures derived from BDNF knockout
embryos were not depleted of cells with the potential while after 2 weeks in vitro, it decreases the size of
these neurons and reduces the number of their primaryto express more NPY immunoreactivity, we treated the
cultures with 20 ng/ml BDNF. Again, the basal numbers dendrites. This later effect is due to a progressive reduc-
tion in size of GABAergic neurons rather than a blockadeof NPY-immunoreactive neurons reflected the genotype
of the animals from which the neurons originated. How- of their growth, since they became smaller than they
were before stimulation.ever, the administration of BDNF brought up the number
of NPY-positive neurons to the same level, irrespective Increase in intracellular calcium is likely to play a cru-
cial role in the trophic effects of GABAA receptor activa-of the genotype (Table 2).
tion on the morphology of developing interneurons.
GABAergic stimulation leads to calcium influx in virtuallyMuscimol Decreases the Size and NPY
Expression of More Mature all immature neurons in hippocampal cultures (Ber-
ninger et al., 1995), and calcium modulates the behaviorHippocampal Interneurons
GABA-immunoreactive neurons in 3-week-old cultures of growth cones through cytoskeletal rearrangements
and organelle movement (Kater and Mills, 1991). On thehad a larger cell soma and more extensive dendritic
arbors than after 1 week (Figure 3a). A 2.5-fold increase other hand, calcium influx induced by muscimol in-
creases BDNF mRNA levels in immature hippocampalin the mean area of the GABAergic soma was observed
between 7 and 16 or 21 days (p < 0.001). neurons (Berninger et al., 1995), and BDNF mimicks the
Activity-Dependent Plasticity of Interneurons
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Figure 2. Muscimol and BDNF Promote the
Differentiation of GABAergic Neurons after 1
Week In Vitro
Effects of 100 mM muscimol and 20 ng/ml
BDNF on the area of the soma of GABAergic
neurons (a), the number of NPY-immunoreac-
tive neurons (b), the total number of cells (c),
the number of GABAergic neurons (d), and
the area of the soma of MAP2-positive neu-
rons (e). Effects of 1 mM muscimol and 10
mM bicuculline on the area of the soma of
GABAergic neurons (f) and the number of
NPY-immunoreactive neurons (g). The cul-
tures were treated for 6 days (starting 1 day
after plating). Results are presented as per-
centages of the control cultures. One aster-
isk, p < 0.05; two asterisks, p < 0.01; three
asterisks p < 0.001.
effect of muscimol on the differentiation of hippocampal we did not observe spontaneous calcium transients be-
fore 15 days in vitro. It indicates that there is not enoughinterneurons. Therefore, BDNF is likely to be involved
in the regulation of the morphology of interneurons via spontaneous GABAergic activity to increase intracellu-
lar calcium and BDNF mRNA in these young cultures.GABAergic stimulation. In contrast with immature cul-
tures, after 2 weeks in vitro, GABAergic activity reduces In contrast with dissociated cell cultures, spontaneous
GABAergic transmission drives neuronal activity (Ben-the levels of intracellular calcium and the synthesis of
BDNF mRNA in hippocampal neurons (Berninger et al., Ari et al., 1989; Hosokawa et al., 1994) and induces
calcium transients (A. Konnerth, personal communica-1995). Accordingly, GABAA receptor stimulation after 2
weeks invitro leadsto an atrophyof GABAergic neurons. tion) in slices from neonatal and early postnatal rat hip-
pocampus, in which connections are retained. There-Thus, GABAergic neurons might regulate their own mor-
phology through the release of GABA, with opposing fore, the effects of GABAergic stimulation reported in
this study are likely to be physiologically relevant.effects dependent upon the stage of maturation. How-
ever, blockade of GABAA receptors with bicuculline did Similar to the effect on cell morphology, GABAA recep-
tor stimulation by muscimol during the first week in vitronot decrease the size of interneurons in the immature
cultures. Accordingly, bicuculline treatment did not leads to an increase in the number of NPY-immunoreac-
tive neurons, while it has an opposite effect after 2lower the basal levels of BDNF mRNA in these cultures
(Berninger et al., 1995). In our dissociated cell cultures, weeks. Since these changes occur without an alteration
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than cultures from (1/1) animals, with cultures fromTable 1. Muscimol Fails to Increase NPY Expression in Cultures
from BDNF Knockout Animals (1/2) animals showing intermediate numbers. Thus,
NPY levels are tightly correlated with the extent of BDNF(1/1) (1/2) (2/2)
expression. Increased neuronal activity in the adult brain
Control Muscimol Control Muscimol Control Muscimol leads to an increase in NPY mRNA (Gall et al., 1990).
49 70 36 47 0 1 Given the up-regulation of BDNF expression (Zafra et
51 141 35 89 0 0 al., 1991; Nawa et al., 1995) and the release of BDNF
41 80 39 51 13 22 after neuronal depolarization (Griesbeck et al., 1995,
43 77 35 36 0 7 Soc. Neurosci., abstract) preceeding the increase in
44 56 23 32 16 17
NPY, it has been postulated that BDNF mediates the30 46 6 10 6 1
effect of neuronal activity on NPY levels (Nawa et al.,34 60 44 46 0 0
18 18 8 2 1995). Indeed, the up-regulation of NPY by muscimol
0 0 was reduced in neurons of BDNF (1/2) embryos and
completely abrogated in cultures of BDNF (2/2) em-42 6 3 76 6 12 30 6 4 41 6 9 5 6 2 6 6 3
bryos. It is not due to an inability of these neurons to
Effects of 100 mM muscimol on the number of NPY-immunoreactive
express NPY, because irrespective of the genotype,cells in 7-day-old cell cultures prepared from control embryos (1/1)
stimulation with BDNF increased their number to theand embryos heterozygous (1/2) or homozygous (2/2) for the mu-
tation of the BDNF gene. The cultures were treated for 6 days (start- same level. Thus, hippocampal interneurons might regu-
ing 1 day after plating). For each embryo, thenumber of NPY-positive late their own neuropeptide pattern through GABAergic
cells in the control cultures is presented beside the value obtained transmission, with BDNF being the mediator in this pro-
in the muscimol-treated culture. At the bottom of each column, the cess. Since muscimol does not up-regulate BDNF
mean value is presented, together with the standard error to the
mRNA in glial cultures (data not shown), BDNF mustmean. Significant differences were found between (1/1) and (1/2)
be produced by neurons. However, hippocampal in-controls (p 5 0.0451), between (1/2) and (2/2) controls (p 5
0.0001), and between (1/1) control and (1/1) treated with muscimol terneurons do not express BDNF themselves (Ernfors
(p 5 0.0159). Although muscimol seemed to increase the number et al., 1990; M. Berzaghi, personal communication).
of NPY-immunoreactive neurons in cultures from (1/2) embryos, Therefore, in early developmental stages, when GABA
the difference did not reach statistical significance. has a depolarizing effect, GABA released from interneu-
rons will increase BDNF production by, and release
from, other neurons. Thus, BDNF acts in a paracrine
in the number of GABAergic neurons and since NPY manner to promote NPY expression in interneurons. In
colocalizes with GABA (data not shown), the observed more maturecultures, when GABA has a hyperpolarizing
effects represent a change in the phenotype of the in- effect on neurons, it reduces BDNF mRNA levels and
terneurons rather than survival, and they are mediated BDNF release, and accordingly, the activity of interneu-
by BDNF. rons may repress their own expression of NPY.
BDNF was shown to regulate NPY mRNA and protein
levels (Nawa et al., 1994), and BDNF knockout mice
Experimental Proceduresexhibit lower levels of NPY immunostaining (Jones et al.,
1994). Accordingly, primary cultures from BDNF (2/2)
Cultures of Dissociated Hippocampal Neuronsembryos contain less NPY-immunoreactive neurons
Hippocampal neurons were prepared from E17 rat embryos. Hippo-
campi were incubated for 20 min at 378C in phosphate-buffered
saline (PBS) without Ca21 or Mg21, containing 10 mM glucose, 1Table 2. BDNF Increases NPY Expression in Cultures from
mg/ml bovine serum albumin (Sigma), 1 mg/ml DNase (Sigma), andBDNF Knockout Animals
12 mg/ml papain (Sigma), dissociated with a plastic pipette, and
(1/1) (1/2) (2/2) centrifuged (5 min at 1000 rpm). Cells were resuspended in Dulbec-
co's modified Eagle's medium containing 10% fetal calf serumControl BDNF Control BDNF Control BDNF
(GIBCO). We plated 5 3 105 cells/well in 24-well plates (Costar). The
110 459 100 602 8 409 medium was changed the next day to defined medium as described
80 323 44 686 2 542 previously (Zafra et al., 1991).
42 680 37 397 2 521 Mutation of themouse BDNF locus was generated by homologous
35 453 0 436 recombination as described by Korte et al. (1995). Heterozygous
26 613 progeny were identified by Southern blotting (Korte et al., 1995).
21 429 Hippocampal neurons were prepared from E17 mice embryos ob-
15 482 tained from pregnant mice generated by crossing of heterozygotes.
5 440 Each embryo was processed separately according to the protocol
described above, and the cells were plated in two different wells,77 6 20 487 6 104 35 6 10 513 6 37 3 6 2 477 6 32
one as control while the other was stimulated.
Effects of 20 ng/ml BDNF on the number of NPY-immunoreactive A single addition of muscimol or bicuculline (Sigma) was made
cells in 7-day-old cell cultures prepared from control embryo (1/1) to the cultures. We applied 20 ng/ml recombinant human BDNF
and embryos heterozygous (1/2) or homozygous (2/2) for the mu- (Regeneron Pharmaceuticals) twice to the cultures with 3 days in-
tation of the BDNF gene. The cultures were treated for 6 days (start- terval.
ing 1 day after plating). The values in the control cultures are ordered
as a function of the number of NPY-immunoreactive cells. For each
Immunocytochemistryembryo, the number of NPY-positive cells in the control culture
The cells were fixed for 20 min in 4% paraformaldehyde in PBS,is presented beside the corresponding value in the BDNF-treated
treated for 30 min in PBS containing 0.5% Triton X-100 and 3%culture. At the bottom of each column, the mean value is presented,
normal goat serum (Sigma), and incubated overnight at 48C withtogether with the standard error to the mean.
antibodies raised against GABA (1:1000; A-2052, Sigma), NPY
Activity-Dependent Plasticity of Interneurons
569
Figure 3. Effect of Muscimol on GABAergic
Neurons after 3 Weeks In Vitro
GABAergic neurons in control (a) and musci-
mol-treated (b) cultures. The cultures were
treated with 100 mM muscimol for 6 days,
starting 15 days after plating. Scale bar, 50
mm.
Figure 4. Muscimol Decreases the Size and
NPY Expression of GABAergic Neurons after
3 Weeks In Vitro
Effects of 100 mM muscimol on the soma area
of GABAergic neurons (a), the number of pri-
mary dendrites of GABAergic neurons (b), the
number of NPY-immunoreactive neurons (c),
the total number of cells (d), the number of
GABAergic neurons (e), and the soma area of
GABAergic neurons after 1 day of treatment
(f). The cultures were treated for 6 days (a±e)
or 1 day (f), starting 15 days after plating.
Results are presented as percentages of the
control cultures, except in (b) in which abso-
lute values are presented. Two asterisks, p <
0.01; three asterisks, p < 0.001.
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(1:2000; RPN-1702, Amersham), or MAP2 (1:400; 1284 959, Boeh- neuropeptide regulation, and mRNA expression in the hippocam-
pus. Prog. Brain Res. 83, 371±390.ringer). The cells were then incubated for 1 hr with corresponding
biotinylated antisera (1:100; Vector Labs) followed by an avidin± Hofer, M., Pagliusi, S.R., Hohn, A., Leibrock, J., and Barde, Y.-A.
biotin±horseradish peroxidase complex for 1 hr (1:100; Vector Labs). (1990). Regional distribution of brain-derived neurotrophic factor
Staining was developed with a diaminobenzidine solution (Sigma). mRNA in the adult mouse brain. EMBO J. 9, 2459±2464.
We were not able to obtain satisfactory GABA immunostaining in Hosokawa, Y., Sciancalepore, M., Stratta, F., Martina, M., and Cher-
cultures from mice, and we therefore concentrated on NPY immuno- ubini, E. (1994). Developmental changes in spontaneous GABAA-staining for the study using murine cultures. mediated synaptic events in rat hippocampal CA3 neurons. Eur. J.
Neurosci. 6, 805±813.
Quantification Jones, K.R., FarinÄ as, I., Backus, C., and Reichardt, L.F. (1994). Tar-
Each quantitation using cultures of dissociated cells from rats was geted disruption of the BDNF gene perturbs brain and sensory neu-
performed on four treated wells compared with four adjacent control ron development but not motor neuron development. Cell 76,
wells and verified in at least two independent experiments. Quantifi- 989±999.
cation of cultures from mice was performed without prior knowledge
Kater, S.B., and Mills, L.R. (1991). Regulation of growth cone behav-of the genotype.
ior by calcium. J. Neurosci. 11, 891±899.In 1-week-old cultures, quantitation of the total number of cells
Korte, M., Carroll, P., Wolf, E., Brem, G., Thoenen, H., and Bonhoef-and the number and area of GABA- or MAP2-immunoreactive neu-
fer, T. (1995). Hippocampal long-term potentiation is impaired inrons was performed using a 203 objective lens in a 72,900 mm2
BDNF-deficient mice. Proc. Natl. Acad. Sci. USA 92, 8856±8860.square, the number of NPY-immunoreactive cells in a 133,225 mm2
square. The cells contacting two of the sides of the square were Marty, S., Carroll, P., Cellerino, A., CastreÂ n, E., Staiger, V., Thoenen,
excluded. The samples were taken from a random starting point H., and Lindholm, D. (1996). Brain-derived neurotrophic factor pro-
every 12 visual fields for the soma area of MAP2-positive neurons, motes the differentiation of various hippocampal non-pyramidal
every 6 visual fields for the total density of cells, every second visual neurons, including Cajal±Retzius cells, in organotypic slice cultures.
field for the soma area and density of GABA-immunoreactive cells, J. Neurosci., in press.
and every visual field for the density of NPY-immunoreactive cells. Nawa, H., Pelleymounter, M.A.,and Carnahan, J. (1994). Intraventric-
The soma area of GABAergic or MAP2-positive neurons (not includ- ular administration of BDNF increases neuropeptide expression in
ing proximal dendrites) was measured on a video screen (Trinitron, newborn rat brain. J. Neurosci. 14, 3751±3765.
Sony) connected to the microscope by an ICCD camera (C2400-87,
Nawa, H., Carnahan, J., and Gall, C. (1995). BDNF protein measuredHamamatsu), using an Argus-10 image processor (Hamamatsu). In
by a novel enzyme immunoassay in normal brain and after seizure:more mature cultures, all the GABA- and NPY-positive cells and
partial disagreement with mRNA levels. Eur. J. Neurosci. 7, 1527±the number of primary dendrites of the GABAergic neurons were
1535.counted, and the area of all of the GABA-immunoreactive neurons
Schousboe, A., and Redburn, D.A. (1995). Modulatory actions ofwas measured.
g-aminobutyric acid (GABA) on GABA type A receptor subunit ex-For each parameter, the mean value and the standard error to
pression and function. J. Neurosci. Res. 41, 1±7.the mean were calculated. Statistical analysis was performed using
the unpaired Student's t test. Yuste, R., and Katz, L.C. (1991). Control of postsynaptic Ca21 influx
in developing neocortex by excitatory and inhibitory neurotransmit-
ters. Neuron 6, 333±344.Acknowledgments
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